NRAS and colorectal carcinoma: We further study the contribution of specific mutations in six clinically-relevant genes (APC, TP53, KRAS, NRAS, PIK3CA and BRAF) to the mutational burden of CRC by measuring variant allele frequencies using targeted ultra-deep sequencing.